Prescription Drugs

FDA acts on a key FREOPP recommendation for lowering the price of unaffordable prescription drugs.

An innovative new rule will encourage Medicare plans to pit injectable and oral drugs against each other.

Both focus on the power of competition and negotiation to make more medicines affordable.

The key to lower costs for patients is to remove federal barriers to pharmaceutical competition.

Drugs are getting less affordable each year. Free-market ideas can bring drug prices down.